Boehringer Ingelheim has appointed Lykke Hinsch Gylvin as its new head of medicine and chief medical officer, succeeding Mehdi Shahidi, who left the position earlier this year after three y
To address the supply chain vulnerabilities of the pharma industry, an innovative, collaborative blockchain-based system could help to keep track of drugs in transit and ensure they are sto
The sooner a human-centred perspective is applied to the development of either a drug or device product, the more likely the product will be adopted and used because it’s been designed arou
In response to the recent Association of British Pharmaceutical Industry (ABPI) report, which showed a sharp decline (41%) in clinical trials initiated by the UK in the period 2017 to 2021,
